AIM ImmunoTech (AIM) Financial Statements

1,003 Followers

AIM ImmunoTech Financial Overview

AIM ImmunoTech's market cap is currently $5.84M. The company's EPS TTM is $-1.8158; its P/E ratio is -0.14; AIM ImmunoTech is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Dec 24	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	$ 88.00K	$ 170.00K	$ 202.00K	$ 141.00K	$ 135.00K
Gross Profit	$ -250.00K	$ 139.00K	$ 160.00K	$ 565.00K	$ -715.00K
Operating Income	$ -10.53M	$ -19.77M	$ -31.92M	$ -19.92M	$ -18.84M
EBITDA	$ -10.32M	$ -16.49M	$ -28.72M	$ -19.87M	$ -18.29M
Net Income	$ -13.96M	$ -17.32M	$ -28.96M	$ -19.45M	$ -19.13M
Balance Sheet
Cash & Short-Term Investments	$ 993.00K	$ 3.98M	$ 13.07M	$ 34.19M	$ 48.27M
Total Assets	$ 5.78M	$ 8.61M	$ 19.38M	$ 40.49M	$ 57.70M
Total Debt	$ 4.90M	$ 2.94M	$ 718.00K	$ 837.00K	$ 149.00K
Net Debt	$ 3.96M	$ 1.24M	$ -4.72M	$ -26.22M	$ -31.94M
Total Liabilities	$ 15.56M	$ 9.93M	$ 9.15M	$ 2.02M	$ 820.00K
Stockholders' Equity	$ -9.78M	$ -1.32M	$ 10.23M	$ 38.47M	$ 56.88M
Cash Flow
Free Cash Flow	$ -10.96M	$ -14.91M	$ -21.85M	$ -16.38M	$ -14.60M
Operating Cash Flow	$ -10.96M	$ -14.89M	$ -21.27M	$ -16.11M	$ -13.96M
Investing Cash Flow	$ 1.85M	$ 4.71M	$ -832.00K	$ 10.99M	$ -631.00K
Financing Cash Flow	$ 10.39M	$ 6.44M	$ 485.00K	$ 80.00K	$ 8.19M

Currency in USD

AIM ImmunoTech Earnings and Revenue History

Income Statement >

AIM ImmunoTech Debt to Assets

Balance Sheet >

AIM ImmunoTech Cash Flow

Cash Flow >

AIM ImmunoTech Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >